Sign In
Buy BBH
$181.73
-4.21 (-2.26%)
At Close: Jun 02, 2026
Where Are Biotech ETFs Headed After Q4 Earnings?
05:51pm, Wednesday, 14'th Feb 2024
Look into how Biotech ETFs performed after Q4 earnings.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:21am, Monday, 12'th Feb 2024
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Biotech ETFs Stage Solid Comeback at the Start of 2024
12:47pm, Tuesday, 09'th Jan 2024
The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-
AI Advancements Could Be Boon for Biotech Industry
10:07am, Wednesday, 03'rd Jan 2024
Generative artificial intelligence was a point of emphasis for investors in 2023. That movement is just getting started.
VanEck Announces Year-End Distributions for VanEck Equity ETFs
07:57pm, Friday, 15'th Dec 2023
NEW YORK--(BUSINESS WIRE)--VanEck announced today the 2023 annual distributions per share for its VanEck® equity exchange-traded funds.
BBH: A Solid Way To Play A Comeback In Biotech
11:08am, Saturday, 09'th Dec 2023
Biotech sector has potential for outperformance in the next year. VanEck Biotech ETF is a good product to consider for exposure to the sector. BBH focuses on large-cap biotech stocks, offering a more
VettaFi Voices On: The Outlook for 2024
03:08pm, Friday, 08'th Dec 2023
Good morning, VettaFi Voices! We are a week out from the VettaFi 2024 Market Outlook Symposium on December 14, which will feature a range of ETF industry leaders discussing their expectations for diff
Should You Invest in the VanEck Biotech ETF (BBH)?
07:32am, Wednesday, 11'th Oct 2023
The VanEck Biotech ETF (BBH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
BBH: Our Favorite Biotech ETF Can Keep Outperforming
03:08am, Wednesday, 13'th Sep 2023
VanEck Biotech ETF has outperformed alternative industry ETFs in recent years through its concentration in large-cap leaders. Biotech companies are benefiting from new artificial intelligence tools se
Time for Gilead Sciences-Heavy ETFs?
03:05pm, Tuesday, 12'th Sep 2023
Bank of America expects the Gilead Sciences to jump about 30%, as quoted on CNBC.
Biotech Still Has Disruptive Capabilities
01:01pm, Friday, 18'th Aug 2023
In what feels like an eternity in biotechnology terms, broader baskets of the industry's stocks haven't outperformed the S&P 500 Health Care Index annually since 2020. That streak could end this year,
Should You Invest in the VanEck Biotech ETF (BBH)?
07:47am, Friday, 11'th Aug 2023
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
Is Now the Right Time to Embrace Biotech ETFs?
12:34pm, Wednesday, 12'th Jul 2023
Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
03:37pm, Thursday, 22'nd Jun 2023
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:30am, Wednesday, 31'st May 2023
Launched on 12/20/2011, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.
